Artwork
iconShare
 
Manage episode 518978286 series 2433414
Content provided by Mark Ebell. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mark Ebell or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Primary care physicians Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell want you to know about 4 new studies: the best choice of pharmacotherapy in hypertensive disorders of pregnancy, benefits and harms of intensive BP lowering, elinzanetant for therapy-induced vasomotor symptoms in women with breast cancer, and 23 year follow up of the European Prostate Cancer Screening Trial. Plus a confusing quiz question (thanks Gary!).

Links

Essential Evidence Plus: www.essentialevidenceplus.com

HTN in pregnancy: https://pubmed.ncbi.nlm.nih.gov/40216176/

Intensive BP lowering: https://pubmed.ncbi.nlm.nih.gov/40902616/

Elinzanetant for vasomotor symptoms in patients taking tamoxifen or anastrozole: https://pubmed.ncbi.nlm.nih.gov/40454634/

23 year follow-up of large European prostate cancer study: https://pubmed.ncbi.nlm.nih.gov/41160819/

  continue reading

194 episodes